EMEND
NDC 0006-3061, FOSAPREPITANT DIMEGLUMINE, injection, powder, lyophilized, for solution, from Merck Sharp & Dohme LLC.
- Product NDC
- 0006-3061
- Status
- Listed
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022023
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3061 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FOSAPREPITANT DIMEGLUMINE150 mg/5mL
Pharmacologic classes
Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0006-3061-00 | 00006306100 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3061-00) / 5 mL in 1 VIAL, SINGLE-DOSE (0006-3061-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8d66803a-6811-4c29-9c57-e16acfa87f21Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0006-3061
Use it
Look up 0006-3061 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3061 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0006-3061. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.